USFDA concludes inspection at Zydus’ LiqMeds in U.K. with four observations
The inspection was conducted from November 9-13, the company said in a regulatory filing to stock exchanges
Account subscription benefits alongside Premium Stories, Editorials, Opinions and more.
Unlock these with Subscription
The View From India Looking at World Affairs from the Indian perspective.
First Day First Show News and reviews from the world of cinema and streaming.
Today's Cache Your download of the top 5 technology stories of the day.
Science For All The weekly newsletter from science writers takes the jargon out of science and puts the fun in!
Data Point Decoding the headlines with facts, figures, and numbers
THEdge At the cutting edge of education and careers
Health Matters Ramya Kannan writes to you on getting to good health, and staying there
Gender Agenda Stories from beyond the binary.
The Hindu On Books Books of the week, reviews, excerpts, new titles and features.
Updated - November 14, 2026 03:13 pm IST - New Delhi
LiqMeds Group was acquired by Zydus Lifesciences via its subsidiary Zydus Pharmaceuticals U.K. in October 2023.
File.
Zydus Lifesciences on Saturday (November 14, 2026) said the U.S. health regulator has concluded its inspection at LiqMeds, U.K., with four observations.
The inspection was conducted from November 9-13, the company said in a regulatory filing to stock exchanges.
"The company will closely work with the U.S.
Food and Drug Administration (USFDA) to address the observations expeditiously," Ahmedabad-based Zydus Lifesciences said.
The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the filing added.
LiqMeds Group was acquired by Zydus Lifesciences via its subsidiary Zydus Pharmaceuticals U.K. in October 2023.
Terms & conditions | Institutional Subscriber
Comments have to be in English, and in full sentences.
They cannot be abusive or personal.
Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform.
If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles.
If you do not have an account please register and login to post comments.
Users can access their older comments by logging into their accounts on Vuukle.
Full detailed coverage is shown on the council website above. Source attribution: The Hindu – Business.
Back to all council news
